Statera Biopharma, Inc. entered into a securities purchase agreement with a number of accredited investors for a private placement of 10,200,000 common shares at a price of $0.075 per share for gross proceeds of $765,000 on November 1, 2022. The company will also issue warrants to purchase 20,400,000 shares at an exercise price of $0.15, with a term of exercise of five years. The warrants are exercisable beginning six months after the date of issuance.

The transaction is expected to close on or about November 15, 2022, subject to the satisfaction of customary closing conditions. The minimum investment accepted from any outside investor is $50,000. The company will issue securities pursuant to exemption provided under Regulation D.